US.SOLV · Solventum

{
  "risk": {
    "level": "Elevated",
    "reason": "risk management score >= 5/10",
    "position": {
      "score": 1.1,
      "details": {
        "atrPct": 3.7565348137867223,
        "turnoverUsdM": 63.39082926,
        "liquidityPoints": 0.4,
        "volatilityPoints": 0.7
      }
    },
    "rrPoints": 1.4,
    "stopLevels": {
      "symbol": "US.SOLV",
      "rr_range": "1:1.0-1:2.5",
      "risk_profile": "中等",
      "stop_loss_price": 79.9642,
      "strength_details": {
        "ma_score": 1.5,
        "atr_score": 1,
        "rsi_score": 3,
        "macd_score": 1.5,
        "volume_score": 1
      },
      "market_adjustment": 1,
      "risk_reward_ratio": 1,
      "stop_loss_percent": 7.5,
      "take_profit_price": 93.1453,
      "target_multiplier": 1.9,
      "technical_strength": 1.63,
      "take_profit_percent": 7.7
    },
    "positionPoints": 1.1,
    "stopLossPoints": 1.2,
    "diversification": {
      "score": 2,
      "details": {
        "method": "sector concentration proxy; no portfolio holdings used",
        "sector": "Health Care",
        "concentratedSectorPenalty": 0
      }
    },
    "riskRewardRatio": 1.2,
    "stopLossPercent": 7.5130696275734445,
    "diversificationPoints": 2
  },
  "total": {
    "max": 160,
    "result": 60.9,
    "formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
    "baseScore": 51.9,
    "modelVersion": "cursor_18_27_news_v2_160",
    "momentum5dScore": 9
  },
  "market": {
    "ma20": 83.499,
    "ma50": 80.078,
    "close": 86.46,
    "prevClose": 85.29,
    "avgVolume20": 1203449,
    "volumeRatio": 0.61,
    "changePercent": 1.37
  },
  "sources": {
    "catalyst": "finnhub_news_keyword_model",
    "sentiment": "finnhub_news_keyword_model",
    "fundamentals": "fmp_stable",
    "institutional": null,
    "marketContext": "twelvedata+fred"
  },
  "barCount": 60,
  "momentum": {
    "max": 50,
    "result": 9,
    "details": {
      "ret_5d": 0.042189006750241065,
      "max_score": 50,
      "max_total": 50,
      "raw_total": 9,
      "vcp_bonus": 0,
      "vol_ratio": 0.5848487386578921,
      "ret_points": 8,
      "vol_points": 0,
      "range_ratio": 0.5022191063157281,
      "volat_points": 0,
      "day_range_pct": 0.016365949572056514,
      "model_version": "cursor_18_27_news_v2_160",
      "available_bars": 30,
      "breakout_points": 0,
      "partial_history": false,
      "pullback_points": 1,
      "breakout_vol_bonus": 0,
      "first_breakout_20d": false,
      "return_window_days": 5,
      "first_breakout_bonus": 0,
      "breakout_quality_points": 0
    },
    "formula": "Cursor_18.25 5D momentum v2 0-50",
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "scoreMax": 110,
  "composite": {
    "max": 160,
    "result": 60.9,
    "formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
    "weights": [
      {
        "raw": 3.4,
        "label": "基本面",
        "weight": "5/110",
        "normalized": 68,
        "contribution": 3.4
      },
      {
        "raw": 10.8,
        "label": "資金流",
        "weight": "20/110",
        "normalized": 54,
        "contribution": 10.8
      },
      {
        "raw": 8.6,
        "label": "市場環境",
        "weight": "15/110",
        "normalized": 57.33,
        "contribution": 8.6
      },
      {
        "raw": 2,
        "label": "催化劑",
        "weight": "20/110",
        "normalized": 10,
        "contribution": 2
      },
      {
        "raw": 5.7,
        "label": "風險管理",
        "weight": "10/110",
        "normalized": 57,
        "contribution": 5.7
      },
      {
        "raw": 17.4,
        "label": "技術信號",
        "weight": "30/110",
        "normalized": 58,
        "contribution": 17.4
      },
      {
        "raw": 4,
        "label": "情緒分析",
        "weight": "10/110",
        "normalized": 40,
        "contribution": 4
      }
    ],
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "momentumMax": 50,
  "scoreStatus": "incomplete",
  "standard110": {
    "rating": "避免",
    "result": 51.9,
    "details": [
      "基本面分析總分: 3.4/5分",
      "資金流分析總分: 10.8/20分",
      "市場環境分析總分: 8.6/15分",
      "催化劑分析: 2/20分",
      "風險管理總分: 5.7/10分",
      "技術信號分析總分: 17.4/30分",
      "情緒分析: 4/10分",
      "共振率(僅顯示不加分): 0%"
    ],
    "formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
    "dimensionScores": {
      "催化劑": 2,
      "基本面": 3.4,
      "資金流": 10.8,
      "市場環境": 8.6,
      "情緒分析": 4,
      "技術信號": 17.4,
      "風險管理": 5.7
    },
    "dimensionDetails": {
      "催化劑": {
        "max": 20,
        "grade": "較差",
        "items": {
          "catalyst": {
            "score": 2,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "catalystCount": 0
            }
          },
          "catalystPoints": 2
        }
      },
      "基本面": {
        "max": 5,
        "grade": "一般",
        "items": {
          "pbPoints": 0.4,
          "pePoints": 0.5,
          "epsPoints": 0,
          "roePoints": 0.75,
          "debtPoints": 0.4,
          "marginPoints": 0.4,
          "turnoverUsdM": 63.39082926,
          "volumePoints": 0.5,
          "revenuePoints": 0,
          "dividendPoints": 0,
          "marketCapPoints": 0.4
        },
        "source": "fmp_stable"
      },
      "資金流": {
        "max": 20,
        "grade": "較差",
        "items": {
          "cmfPoints": 2.4,
          "mfiPoints": 2.4,
          "obvPoints": 0.8,
          "vwapPoints": 3.2,
          "institutional": {
            "score": 2,
            "details": {
              "source": "optional-neutral",
              "warning": {
                "code": "INSTITUTIONAL_DATA_OPTIONAL",
                "symbol": "US.SOLV",
                "message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
              },
              "optional": true,
              "holderCount": null,
              "holderPoints": 2,
              "top10ShareRatio": null,
              "concentrationPenalty": 0
            }
          },
          "institutionPoints": 2
        }
      },
      "市場環境": {
        "max": 15,
        "grade": "較差",
        "items": {
          "vix": {
            "score": 0,
            "details": {
              "source": "twelvedata+fred",
              "missing": true,
              "vixClose": null
            }
          },
          "trend": {
            "score": 3.4,
            "details": {
              "qqq": {
                "ma20": 702.3384985500002,
                "ma50": 713.21300206,
                "name": "QQQ",
                "close": 732.070007,
                "points": 1.4
              },
              "spy": {
                "ma20": 754.5440030999999,
                "ma50": 748.4844041399998,
                "name": "SPY",
                "close": 777.88,
                "points": 2
              },
              "source": "twelvedata+fred"
            }
          },
          "atrPct": 3.7565348137867223,
          "atrPoints": 2,
          "cciPoints": 3.2,
          "vixPoints": 0,
          "marketTrendPoints": 3.4
        }
      },
      "情緒分析": {
        "max": 10,
        "grade": "較差",
        "items": {
          "sentiment": {
            "score": 4,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "negativeHits": 0,
              "positiveHits": 2,
              "sentimentScoreRaw": 0.6
            }
          },
          "sentimentData": {
            "raw": [
              {
                "id": 141202736,
                "url": "https://finnhub.io/api/news?id=1de5109a4997c36359eb80845578eba6dc4ee9bf54b859017205fb7ca2c044eb",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SOLV",
                "summary": "CEO Hanson discusses HIS separation strategy and $2.2B in quarterly sales growth.",
                "category": "company",
                "datetime": 1786582968,
                "headline": "Solventum (SOLV) Q2 2026 Earnings Call Transcript"
              },
              {
                "id": 141183734,
                "url": "https://finnhub.io/api/news?id=68d85bdd6def338a40765b4f619a75c6032d416da0c8e5efae1da55b061f8099",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SOLV",
                "summary": "Healthcare solutions provider Solventum (NYSE:SOLV) reported revenue ahead of Wall Street’s expectations in Q2 CY2026, with sales up 2.2% year on year to $2.21 billion. Its non-GAAP profit of $2.55 per share was 33.8% above analysts’ consensus estimates.",
                "category": "company",
                "datetime": 1786441282,
                "headline": "SOLV Q2 Deep Dive: Portfolio Restructuring and ERP Transition Shape Outlook"
              },
              {
                "id": 141165627,
                "url": "https://finnhub.io/api/news?id=4c18f0b8f2ecf2208f890041dddb9fed5118c68863434e4a9fbf2fbd5cb2e082",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SOLV",
                "summary": "Solventum’s analyst fair value estimate has been revised from US$82.15 to US$93.15, a shift of about 13% in the updated framework. This adjustment aligns with recent analyst commentary that points to Q2 results, the planned Health Information Systems separation, and views on the company’s MedTech focus as reasons to revisit price targets. Read on to see how these factors shape the evolving Solventum narrative and what to watch as new data comes in. Analyst Price Targets don't always capture...",
                "category": "company",
                "datetime": 1786262983,
                "headline": "Solventum (SOLV) Stock Fair Value Rises After Q2 And HIS Separation Plans"
              },
              {
                "id": 141131716,
                "url": "https://finnhub.io/api/news?id=a57df246be907a38a314d3e376968bcbe773e8865d03a98f7958af8e0fa93f38",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SOLV",
                "summary": "Solventum Corp (SOLV) beats Q2 expectations with 9.5% organic growth, announces HIS separation, and raises full-year guidance.",
                "category": "company",
                "datetime": 1785992755,
                "headline": "Solventum Corp (SOLV) (Q2 2026) Earnings Call Highlights: Strong Growth and Strategic ..."
              },
              {
                "id": 141129406,
                "url": "https://finnhub.io/api/news?id=b620bf515142c918d81f4d3fe3d39e8ab913797fead9081cbc74705e35398c65",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SOLV",
                "summary": "Solventum (SOLV) delivered earnings and revenue surprises of +33.51% and +2.03%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?",
                "category": "company",
                "datetime": 1785967808,
                "headline": "Solventum (SOLV) Q2 Earnings and Revenues Top Estimates"
              },
              {
                "id": 141129407,
                "url": "https://finnhub.io/api/news?id=c93f0a20e4bd483d9187d72f1e9c4b97f7c93123e7927042ea1036750c30b105",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SOLV",
                "summary": "The headline numbers for Solventum (SOLV) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.",
                "category": "company",
                "datetime": 1785967203,
                "headline": "Solventum (SOLV) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates"
              },
              {
                "id": 141129408,
                "url": "https://finnhub.io/api/news?id=1c938c7ad57b9b581cbb2c48be8b9c2ee37fb3607ff3de332b3cbf19854cc86e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SOLV",
                "summary": "Healthcare solutions provider Solventum (NYSE:SOLV) reported Q2 CY2026 results topping the market’s revenue expectations, with sales up 2.2% year on year to $2.21 billion. Its non-GAAP profit of $2.55 per share was 33.8% above analysts’ consensus estimates.",
                "category": "company",
                "datetime": 1785963999,
                "headline": "Solventum (NYSE:SOLV) Posts Better-Than-Expected Sales In Q2 CY2026"
              },
              {
                "id": 141129798,
                "url": "https://finnhub.io/api/news?id=a6167a4079c8eee5709eecf50af08823d78fa4e35dca1b815945517c4c43e660",
                "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
                "source": "SeekingAlpha",
                "related": "SOLV",
                "summary": "Solventum Corporation (SOLV) Q2 2026 Earnings Call August 5, 2026 4:30 PM EDTCompany ParticipantsAmy Wakeham - Senior Vice President of Investor Relations...",
                "category": "company",
                "datetime": 1785963605,
                "headline": "Solventum Corporation (SOLV) Q2 2026 Earnings Call Transcript"
              }
            ],
            "raw_source": [
              {
                "id": 141202736,
                "url": "https://finnhub.io/api/news?id=1de5109a4997c36359eb80845578eba6dc4ee9bf54b859017205fb7ca2c044eb",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SOLV",
                "summary": "CEO Hanson discusses HIS separation strategy and $2.2B in quarterly sales growth.",
                "category": "company",
                "datetime": 1786582968,
                "headline": "Solventum (SOLV) Q2 2026 Earnings Call Transcript"
              },
              {
                "id": 141197531,
                "url": "https://finnhub.io/api/news?id=0ad00594b320b2b62379bd020b3f4d60a6b2410c1cb6d0ad82ea849220b24214",
                "image": "",
                "source": "SeekingAlpha",
                "related": "SOLV",
                "summary": "",
                "category": "company",
                "datetime": 1786564051,
                "headline": "Tracking Christopher Davis' Davis Selected Advisers 13F Portfolio: Q2 2026 Update"
              },
              {
                "id": 141183734,
                "url": "https://finnhub.io/api/news?id=68d85bdd6def338a40765b4f619a75c6032d416da0c8e5efae1da55b061f8099",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SOLV",
                "summary": "Healthcare solutions provider Solventum (NYSE:SOLV) reported revenue ahead of Wall Street’s expectations in Q2 CY2026, with sales up 2.2% year on year to $2.21 billion. Its non-GAAP profit of $2.55 per share was 33.8% above analysts’ consensus estimates.",
                "category": "company",
                "datetime": 1786441282,
                "headline": "SOLV Q2 Deep Dive: Portfolio Restructuring and ERP Transition Shape Outlook"
              },
              {
                "id": 141165627,
                "url": "https://finnhub.io/api/news?id=4c18f0b8f2ecf2208f890041dddb9fed5118c68863434e4a9fbf2fbd5cb2e082",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SOLV",
                "summary": "Solventum’s analyst fair value estimate has been revised from US$82.15 to US$93.15, a shift of about 13% in the updated framework. This adjustment aligns with recent analyst commentary that points to Q2 results, the planned Health Information Systems separation, and views on the company’s MedTech focus as reasons to revisit price targets. Read on to see how these factors shape the evolving Solventum narrative and what to watch as new data comes in. Analyst Price Targets don't always capture...",
                "category": "company",
                "datetime": 1786262983,
                "headline": "Solventum (SOLV) Stock Fair Value Rises After Q2 And HIS Separation Plans"
              },
              {
                "id": 141165223,
                "url": "https://finnhub.io/api/news?id=93eca12886e802999219a5a8489f912ff2aad29671ed276e05cc92c1dc62882d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SOLV",
                "summary": "Solventum (NYSE:SOLV) reported second-quarter results that exceeded its internal expectations, supported by broad-based segment performance, planned order activity ahead of an ERP cutover and a tariff refund benefit. The company also announced plans to separate its Health Information Systems, or HIS",
                "category": "company",
                "datetime": 1786259037,
                "headline": "Solventum Q2 Earnings Call Highlights"
              },
              {
                "id": 141138338,
                "url": "https://finnhub.io/api/news?id=66be9094570456fc28b35eb99f3c6ef5f0fc41d34be1f1ed72e8a3ae5118c97d",
                "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
                "source": "ChartMill",
                "related": "SOLV",
                "summary": "Stay informed about the performance of the S&P500 index one hour before the close of the markets on Thursday. Uncover the top gainers and losers in today's session for valuable insights.",
                "category": "company",
                "datetime": 1786043101,
                "headline": "Explore the top gainers and losers within the S&P500 index in today's session."
              },
              {
                "id": 141140627,
                "url": "https://finnhub.io/api/news?id=821a2ebea1801a2ec5b1d31db9ec33eb8b6e8f606927bd12df7b938a1445bd09",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SOLV",
                "summary": "SOLV's Q2 earnings and revenues beat estimates as organic sales increase 9.5%, prompting higher 2026 guidance despite ERP timing benefits.",
                "category": "company",
                "datetime": 1786038780,
                "headline": "Solventum Stock Up as Q2 Earnings & Revenues Beat Estimates"
              },
              {
                "id": 141138455,
                "url": "https://finnhub.io/api/news?id=cd2ea0994254f995f5728da18bd18ae97c339fdf1afcd315d54bb652f0c0a45f",
                "image": "",
                "source": "Benzinga",
                "related": "SOLV",
                "summary": "UBS  analyst Kevin Caliendo   maintains Solventum (NYSE:SOLV) with a Buy and raises the price target from $95 to $101.",
                "category": "company",
                "datetime": 1786027965,
                "headline": "UBS Maintains Buy on Solventum, Raises Price Target to $101"
              },
              {
                "id": 141138457,
                "url": "https://finnhub.io/api/news?id=d99aedf3913de0c8c7ab6dd95319df5c6c673925a60bfcd35977af9e9fca7566",
                "image": "",
                "source": "Benzinga",
                "related": "SOLV",
                "summary": "Piper Sandler  analyst Jason Bednar   maintains Solventum (NYSE:SOLV) with a Overweight and raises the price target from $92 to $105.",
                "category": "company",
                "datetime": 1786020387,
                "headline": "Piper Sandler Maintains Overweight on Solventum, Raises Price Target to $105"
              },
              {
                "id": 141158422,
                "url": "https://finnhub.io/api/news?id=35a880cc1b13972c3b655c0a1e0ac0ccc31098c39bf7217c0fdb8ec011deeef2",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SOLV",
                "summary": "Moby summary of Solventum Corporation's Q2 2026 earnings call",
                "category": "company",
                "datetime": 1786019400,
                "headline": "Solventum Corporation Q2 2026 Earnings Call Summary"
              },
              {
                "id": 141138458,
                "url": "https://finnhub.io/api/news?id=da8f44787e47c4c689b389e77197e7bdd1d344b6495da7e404238f731536b601",
                "image": "",
                "source": "Benzinga",
                "related": "SOLV",
                "summary": "Wedbush  analyst Michael Piccolo   maintains Solventum (NYSE:SOLV) with a Outperform and raises the price target from $94 to $101.",
                "category": "company",
                "datetime": 1786016675,
                "headline": "Wedbush Maintains Outperform on Solventum, Raises Price Target to $101"
              },
              {
                "id": 141138459,
                "url": "https://finnhub.io/api/news?id=5b25ff46b87e42a1b94b37eada3e1ace3a6adc71adfb51d75f19a047ce426f3f",
                "image": "",
                "source": "Benzinga",
                "related": "SOLV",
                "summary": "Keybanc  analyst Brett Fishbin   maintains Solventum (NYSE:SOLV) with a Overweight and raises the price target from $93 to $102.",
                "category": "company",
                "datetime": 1786012912,
                "headline": "Keybanc Maintains Overweight on Solventum, Raises Price Target to $102"
              },
              {
                "id": 141138460,
                "url": "https://finnhub.io/api/news?id=623d39deb358c6a8aac603c759b8d206adca10dd2cf645664dd04c090247537e",
                "image": "",
                "source": "Benzinga",
                "related": "SOLV",
                "summary": "Stifel  analyst Rick Wise   maintains Solventum (NYSE:SOLV) with a Buy and raises the price target from $90 to $100.",
                "category": "company",
                "datetime": 1786011857,
                "headline": "Stifel Maintains Buy on Solventum, Raises Price Target to $100"
              },
              {
                "id": 141135743,
                "url": "https://finnhub.io/api/news?id=5af91292874d9542e291856e56340dae0e6cd9e3b0caf5e50b6a89f886dfedff",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SOLV",
                "summary": "The software business needs “a different investment level” to quickly realize its potential, Solventum’s CEO said.",
                "category": "company",
                "datetime": 1786010400,
                "headline": "Solventum plans software separation to become ‘true medtech company’"
              },
              {
                "id": 141138461,
                "url": "https://finnhub.io/api/news?id=0fc86e65619d0648913b889e875c352b66cf94ed6f04329d1391a672b9d540c2",
                "image": "",
                "source": "Benzinga",
                "related": "SOLV",
                "summary": "BTIG  analyst Ryan Zimmerman   maintains Solventum (NYSE:SOLV) with a Buy and raises the price target from $91 to $95.",
                "category": "company",
                "datetime": 1785995355,
                "headline": "BTIG Maintains Buy on Solventum, Raises Price Target to $95"
              },
              {
                "id": 141131716,
                "url": "https://finnhub.io/api/news?id=a57df246be907a38a314d3e376968bcbe773e8865d03a98f7958af8e0fa93f38",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SOLV",
                "summary": "Solventum Corp (SOLV) beats Q2 expectations with 9.5% organic growth, announces HIS separation, and raises full-year guidance.",
                "category": "company",
                "datetime": 1785992755,
                "headline": "Solventum Corp (SOLV) (Q2 2026) Earnings Call Highlights: Strong Growth and Strategic ..."
              },
              {
                "id": 141129405,
                "url": "https://finnhub.io/api/news?id=812e993c12ec5f679eb6a7cc5149754ba76c0b38b74c6f34af4130a7764aecdc",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SOLV",
                "summary": "Investing.com -- Solventum Corp (NYSE:SOLV) reported second quarter results that exceeded analyst expectations and raised its full-year guidance, driven by strong organic sales growth across all business segments.",
                "category": "company",
                "datetime": 1785970143,
                "headline": "Solventum beats estimates, raises guidance on strong growth"
              },
              {
                "id": 141129406,
                "url": "https://finnhub.io/api/news?id=b620bf515142c918d81f4d3fe3d39e8ab913797fead9081cbc74705e35398c65",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SOLV",
                "summary": "Solventum (SOLV) delivered earnings and revenue surprises of +33.51% and +2.03%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?",
                "category": "company",
                "datetime": 1785967808,
                "headline": "Solventum (SOLV) Q2 Earnings and Revenues Top Estimates"
              },
              {
                "id": 141129407,
                "url": "https://finnhub.io/api/news?id=c93f0a20e4bd483d9187d72f1e9c4b97f7c93123e7927042ea1036750c30b105",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SOLV",
                "summary": "The headline numbers for Solventum (SOLV) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.",
                "category": "company",
                "datetime": 1785967203,
                "headline": "Solventum (SOLV) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates"
              },
              {
                "id": 141129408,
                "url": "https://finnhub.io/api/news?id=1c938c7ad57b9b581cbb2c48be8b9c2ee37fb3607ff3de332b3cbf19854cc86e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SOLV",
                "summary": "Healthcare solutions provider Solventum (NYSE:SOLV) reported Q2 CY2026 results topping the market’s revenue expectations, with sales up 2.2% year on year to $2.21 billion. Its non-GAAP profit of $2.55 per share was 33.8% above analysts’ consensus estimates.",
                "category": "company",
                "datetime": 1785963999,
                "headline": "Solventum (NYSE:SOLV) Posts Better-Than-Expected Sales In Q2 CY2026"
              },
              {
                "id": 141126827,
                "url": "https://finnhub.io/api/news?id=0c31fe0b2d0caab81d508e5fdaea005a58287c2047d6405ce71ba4ef83761794",
                "image": "https://www.chartmill.com/images/uploads/CM_Aftermarket_Movers_Small_free_e077945a19.webp",
                "source": "ChartMill",
                "related": "SOLV",
                "summary": "As the regular session of the US market on Wednesday comes to an end, let's delve into the after-hours session and discover the top S&P500 gainers and losers shaping the post-market sentiment.",
                "category": "company",
                "datetime": 1785963901,
                "headline": "Stay updated with the S&P500 stocks that are on the move in today's after-hours session."
              },
              {
                "id": 141129792,
                "url": "https://finnhub.io/api/news?id=3fe57ef48ffcab5f3321f3f0b79c7558282ad2541944a6f58cd946969f3b538e",
                "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
                "source": "SeekingAlpha",
                "related": "SOLV",
                "summary": "2026-08-05. The following slide deck was published by Solventum Corporation in conjunction with their 2026 Q2 earnings call.",
                "category": "company",
                "datetime": 1785963765,
                "headline": "Solventum Corporation 2026 Q2 - Results - Earnings Call Presentation"
              },
              {
                "id": 141129798,
                "url": "https://finnhub.io/api/news?id=a6167a4079c8eee5709eecf50af08823d78fa4e35dca1b815945517c4c43e660",
                "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
                "source": "SeekingAlpha",
                "related": "SOLV",
                "summary": "Solventum Corporation (SOLV) Q2 2026 Earnings Call August 5, 2026 4:30 PM EDTCompany ParticipantsAmy Wakeham - Senior Vice President of Investor Relations...",
                "category": "company",
                "datetime": 1785963605,
                "headline": "Solventum Corporation (SOLV) Q2 2026 Earnings Call Transcript"
              },
              {
                "id": 141127666,
                "url": "https://finnhub.io/api/news?id=43314c4ead1b9bc3e3675ba56b9cb909203d870604b076179850602fbd959519",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SOLV",
                "summary": "Solventum (NYSE: SOLV) today reported financial results for the second quarter ended June 30, 2026.",
                "category": "company",
                "datetime": 1785960300,
                "headline": "Solventum Reports Second Quarter 2026 Financial Results"
              },
              {
                "id": 141127665,
                "url": "https://finnhub.io/api/news?id=fa8e2f0cbef44ad001aa898b35d5362c7b6d31327083a849dfad5525d29e727d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SOLV",
                "summary": "Solventum (NYSE: SOLV) today announced its intention to pursue a separation of its Health Information Systems business as part of the company's ongoing portfolio optimization strategy. The company will evaluate a range of separation pathways with the objective of maximizing shareholder value that position both Solventum and Health Information Systems for long-term success.",
                "category": "company",
                "datetime": 1785960300,
                "headline": "Solventum Announces Intent to Separate its Health Information Systems Business"
              },
              {
                "id": 141138462,
                "url": "https://finnhub.io/api/news?id=ecdfacbc8640c99a5ef41259f5b6e9d3b8abc163904c546ed1a8eda9ad9689d2",
                "image": "",
                "source": "Benzinga",
                "related": "SOLV",
                "summary": "Solventum (NYSE: SOLV) today announced its intention to pursue a separation of its Health Information Systems business as part of the company's ongoing portfolio optimization strategy. The company will evaluate a",
                "category": "company",
                "datetime": 1785948810,
                "headline": "Solventum Plans To Separate Its Health Information Systems Operations As Part Of Its Portfolio Optimization Strategy"
              },
              {
                "id": 141138463,
                "url": "https://finnhub.io/api/news?id=e8ccacb5e5d6d8f6e68be1324b3780167547e999e53ec0a57edb9703d017efce",
                "image": "",
                "source": "Benzinga",
                "related": "SOLV",
                "summary": "Solventum (NYSE:SOLV) reported quarterly earnings of $2.55 per share which beat the analyst consensus estimate of $1.91 by 33.51 percent. This is a 50.89 percent increase over earnings of $1.69 per share from the same",
                "category": "company",
                "datetime": 1785946781,
                "headline": "Solventum Q2 Adj. EPS $2.55 Beats $1.91 Estimate, Sales $2.209B Beat $2.156B Estimate"
              },
              {
                "id": 141138464,
                "url": "https://finnhub.io/api/news?id=cdf12920b469880013a240ae54f9d4df3a9153eb5148024f2a6ff1332f0f1058",
                "image": "",
                "source": "Benzinga",
                "related": "SOLV",
                "summary": "Solventum (NYSE:SOLV) raises FY2026 Adj EPS guidance from $6.60 to $7.10-$7.20 vs $6.55 analyst estimate..",
                "category": "company",
                "datetime": 1785946596,
                "headline": "Solventum Raises FY2026 Adj EPS Guidance from $6.60 to $7.10-$7.20 vs $6.55 Est"
              },
              {
                "id": 141114965,
                "url": "https://finnhub.io/api/news?id=a76269cd0057c2594211e58ca0d57d39fd42fa56d0cd555210da965d1354395d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SOLV",
                "summary": "McKesson, Cencora, Solventum and PacBio head into earnings with resilient demand offset by tariffs, funding pressure and pricing challenges.",
                "category": "company",
                "datetime": 1785870480,
                "headline": "What's in Store for These 4 Healthcare Companies This Earnings Season?"
              },
              {
                "id": 141101106,
                "url": "https://finnhub.io/api/news?id=5abe8d9ae172747fe7022fcdf4b95538561fe7641d2aa18259c89c9f3cac727a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SOLV",
                "summary": "SOLV's Q2 results are likely to benefit from segment strength, Acera gains and cost savings, offset by tariffs and ERP-related sales timing shifts.",
                "category": "company",
                "datetime": 1785774960,
                "headline": "Solventum to Report Q2 Earnings: What's in Store for the Stock?"
              },
              {
                "id": 141093867,
                "url": "https://finnhub.io/api/news?id=f313d2251dc4aeb66a33544f649f0fbe55f30728f01035fcaef9d6a2fa471782",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SOLV",
                "summary": "Solventum (NYSE:SOLV) has appointed Neil Zieselman as Senior Vice President, Controller, and Chief Accounting Officer. He will succeed current Controller and Chief Accounting Officer Mary Wilcox following her retirement. Zieselman brings experience from Surgery Partners Inc., Stryker Corporation, Covanta Holding Corporation, Cendant Corporation, and Avaya Inc., and is a licensed CPA. Solventum enters this leadership change with its stock at $85.44 and a value score of 5, which can help...",
                "category": "company",
                "datetime": 1785679682,
                "headline": "Solventum (SOLV) Appoints Neil Zieselman As New Chief Accounting Officer"
              },
              {
                "id": 141081735,
                "url": "https://finnhub.io/api/news?id=ca7e43a601dbfa7de127c36de15b1543fa1cdfc5ba5ebd1947eaadf8732b74ef",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SOLV",
                "summary": "Each stock in this article is trading near its 52-week high. These elevated prices usually indicate some degree of investor confidence, business improvements, or favorable market conditions.",
                "category": "company",
                "datetime": 1785524397,
                "headline": "3 Hyped Up  Stocks That Fall Short"
              },
              {
                "id": 141049828,
                "url": "https://finnhub.io/api/news?id=4d59d6a7e2ebb7fe2d614bd60f7172755659f23996655852da433dcc1b2eab87",
                "image": "",
                "source": "Fintel",
                "related": "SOLV",
                "summary": "",
                "category": "company",
                "datetime": 1785294366,
                "headline": "UBS Upgrades Solventum (SOLV)"
              },
              {
                "id": 141046067,
                "url": "https://finnhub.io/api/news?id=28852786028f830f8c93415f5e5497f7948584b12d1d51d853db9c580c37e955",
                "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
                "source": "ChartMill",
                "related": "SOLV",
                "summary": "Get insights into the S&P500 index performance on Tuesday. Explore the top gainers and losers within the S&P500 index in today's session.",
                "category": "company",
                "datetime": 1785265501,
                "headline": "Exploring the top movers within the S&P500 index during today's session."
              },
              {
                "id": 141046204,
                "url": "https://finnhub.io/api/news?id=5a718149fa4c5903fd1c72528101f79d2754208b7938f5b4c5677e17a8a376bc",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SOLV",
                "summary": "Nelson Peltz just made a healthcare technology spinoff his largest institutional bet, and the combination of a dirt-cheap valuation, an activist legend, and a company still sorting out its own identity creates a setup worth understanding before the market catches on.",
                "category": "company",
                "datetime": 1785264529,
                "headline": "Nelson Peltz and Trian Take a New Position: The Turnaround Thesis"
              },
              {
                "id": 141044608,
                "url": "https://finnhub.io/api/news?id=d914c07964c6e02bbb3d0f3dab99f42869b3f4d48013c90488f66bd1641dc6d2",
                "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
                "source": "ChartMill",
                "related": "SOLV",
                "summary": "Stay updated with the movement of S&P500 stocks in today's session. Discover which S&P500 stocks are making waves on Tuesday.",
                "category": "company",
                "datetime": 1785256501,
                "headline": "Tuesday's session: top gainers and losers in the S&P500 index"
              },
              {
                "id": 141053803,
                "url": "https://finnhub.io/api/news?id=31c0e6032d9065ddb5d0498444448cb28b52262665595ddc28c7f9d17d5e33b4",
                "image": "",
                "source": "Benzinga",
                "related": "SOLV",
                "summary": "UBS  analyst Kevin Caliendo   upgrades Solventum (NYSE:SOLV) from Neutral to Buy and announces $95 price target.",
                "category": "company",
                "datetime": 1785250260,
                "headline": "UBS Upgrades Solventum to Buy, Announces $95 Price Target"
              },
              {
                "id": 141043102,
                "url": "https://finnhub.io/api/news?id=4def2ebd595d4441db1c358c20ea98221169d771dcb6942e98c2c7ed2cec1c4c",
                "image": "https://www.chartmill.com/images/uploads/CM_Gap_Stocks_Small_free_ad767b11cf.webp",
                "source": "ChartMill",
                "related": "SOLV",
                "summary": "Curious about the S&P500 stocks that are gapping on Tuesday? Explore the gap up and gap down stocks in the S&P500 index during today's session.",
                "category": "company",
                "datetime": 1785249301,
                "headline": "These S&P500 stocks are gapping in today's session"
              },
              {
                "id": 141009546,
                "url": "https://finnhub.io/api/news?id=7997fae7bef195a5d0fc284d99f762102b673d55e9bc2d8355b6742d71385f5c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SOLV",
                "summary": "Since January 2026, Solventum has been in a holding pattern, posting a small loss of 2.2% while floating around $77.29. The stock also fell short of the S&P 500’s 7.9% gain during that period.",
                "category": "company",
                "datetime": 1784921828,
                "headline": "3 Reasons SOLV is Risky and 1 Stock to Buy Instead"
              },
              {
                "id": 141006590,
                "url": "https://finnhub.io/api/news?id=b9d1dbac7b295758ca6240d77ce744fd68e68aaf1579f112a00365686f982e57",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SOLV",
                "summary": "SOLV's innovation, cost savings and strong segment demand support growth, while raw material cost increases remain a key risk.",
                "category": "company",
                "datetime": 1784901600,
                "headline": "Here's Why You Should Hold Solventum Stock in Your Portfolio for Now"
              },
              {
                "id": 140985002,
                "url": "https://finnhub.io/api/news?id=efd76616143597f91d13bc7ce0aa525c5e19063cba99e6fba308dcbb0091e803",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SOLV",
                "summary": "Solventum is scheduled to report its fiscal second-quarter results early next month, with analysts expecting a modest year-over-year increase in earnings.",
                "category": "company",
                "datetime": 1784716595,
                "headline": "Solventum’s Q2 2026 Earnings: What to Expect"
              },
              {
                "id": 140971487,
                "url": "https://finnhub.io/api/news?id=630870d4bdb5728275419d4eb9b59537a5f8c9eee4266c7beb5a529086c517a4",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SOLV",
                "summary": "3M (MMM) stock is jumping on Tuesday after the manufacturer raised its full-year guidance. This comes amid 3M's turnaround plan, where the company has turned its attention toward simultaneously simplifying operations and boosting innovations. CFRA Research analyst Jonathan Sakraida highlights what this could all mean for the company, especially as it transitions into gaining more exposure to AI data centers.",
                "category": "company",
                "datetime": 1784646774,
                "headline": "3M investors are still waiting for a more 'consistent' growth story"
              },
              {
                "id": 140049019,
                "url": "https://finnhub.io/api/news?id=7a629db8b449d905f61c4ffdf1b6684b342fcc22ebf1c524d64b1d845debb6ed",
                "image": "",
                "source": "Benzinga",
                "related": "SOLV",
                "summary": "",
                "category": "company",
                "datetime": 1784205329,
                "headline": "Carlsmed Announces Aprevo Bi-Lateral Posterior Lumbar Interbody Fusion Procedure"
              },
              {
                "id": 140914414,
                "url": "https://finnhub.io/api/news?id=fa4f0d3f4d353aaa0481aa531b9eadf6ac90aeda85d677a2eef43bc803010e71",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SOLV",
                "summary": "Solventum (NYSE: SOLV) will release its second quarter fiscal 2026 financial results on Wednesday, August 5, 2026, after the U.S. financial markets close. Following the release, Solventum management will host a webcast to discuss the results. Other forward-looking and material information may also be discussed during the webcast.",
                "category": "company",
                "datetime": 1784145900,
                "headline": "Solventum to Report Second Quarter Fiscal 2026 Earnings on August 5, 2026"
              }
            ],
            "data_source": "finnhub_news_keyword_model",
            "article_count": 8,
            "negative_hits": 0,
            "positive_hits": 2,
            "recomputed_at_score": true,
            "sentiment_score_raw": 0.6,
            "source_article_count": 44,
            "discarded_article_count": 33
          },
          "sentimentPoints": 4
        }
      },
      "技術信號": {
        "max": 30,
        "raw": 17.4,
        "grade": "較差",
        "items": {
          "bbPoints": 3,
          "adxPoints": 3,
          "sarPoints": 1.2000000000000002,
          "vcpPoints": 2.1,
          "macdPoints": 2.4,
          "vcpPayload": {
            "vcp_pass": false,
            "vcp_score": 2.1,
            "vcp_reason": "波幅收縮(17.6%→10.2%)；站上MA50；升放量(近10日2日)；Ready=N；Confirm=Y",
            "vcp_metrics": {
              "up_days": 4,
              "vol_ref": 1151616.6666666667,
              "down_days": 5,
              "vcp_ready": false,
              "above_ma50": true,
              "avg_vol_10": 1344390,
              "avg_vol_20": 1253625,
              "avg_vol_30": 1151616.6666666667,
              "range_pct_10": 0.10154984964145272,
              "range_pct_20": 0.1530187369882027,
              "range_pct_30": 0.176266481609993,
              "up_expand_ok": true,
              "lookback_used": 59,
              "near_20d_high": true,
              "contraction_ok": true,
              "down_shrink_ok": false,
              "up_expand_days": 2,
              "breakout_20d_ok": false,
              "vol_ratio_10_30": 1.1673936639796227,
              "dist_to_20d_high": 0.0393333333333334,
              "down_shrink_days": 2,
              "breakout_level_20d": 90,
              "vcp_breakout_confirm": true,
              "contraction_ratio_10_30": 0.5761154855643048
            },
            "vcp_name_en": "Volatility Contraction Pattern",
            "vcp_name_zh": "波動收縮形態",
            "vol_contraction": true
          },
          "kdjAdxPoints": 0.5,
          "rsiKdjPoints": 2.4,
          "volumeWeight": 2,
          "maCrossPoints": 1.6,
          "shortRsiPoints": 0.4,
          "shortMacdPoints": 0.4,
          "volConfirmPoints": 0,
          "volumePointsTechnical": 0.4
        }
      },
      "風險管理": {
        "max": 10,
        "grade": "較差",
        "items": {
          "position": {
            "score": 1.1,
            "details": {
              "atrPct": 3.7565348137867223,
              "turnoverUsdM": 63.39082926,
              "liquidityPoints": 0.4,
              "volatilityPoints": 0.7
            }
          },
          "rrPoints": 1.4,
          "stopLevels": {
            "symbol": "US.SOLV",
            "rr_range": "1:1.0-1:2.5",
            "risk_profile": "中等",
            "stop_loss_price": 79.9642,
            "strength_details": {
              "ma_score": 1.5,
              "atr_score": 1,
              "rsi_score": 3,
              "macd_score": 1.5,
              "volume_score": 1
            },
            "market_adjustment": 1,
            "risk_reward_ratio": 1,
            "stop_loss_percent": 7.5,
            "take_profit_price": 93.1453,
            "target_multiplier": 1.9,
            "technical_strength": 1.63,
            "take_profit_percent": 7.7
          },
          "positionPoints": 1.1,
          "stopLossPoints": 1.2,
          "diversification": {
            "score": 2,
            "details": {
              "method": "sector concentration proxy; no portfolio holdings used",
              "sector": "Health Care",
              "concentratedSectorPenalty": 0
            }
          },
          "riskRewardRatio": 1.2,
          "stopLossPercent": 7.5130696275734445,
          "diversificationPoints": 2
        }
      }
    }
  },
  "modelVersion": "cursor_18_27_news_v2_160",
  "providerErrors": [
    {
      "code": "VIX_MISSING",
      "symbol": "US.SOLV",
      "message": "VIX market context is required for market environment scoring",
      "missing": [
        "VIX"
      ],
      "provider": "scoring"
    }
  ],
  "rankingScoreMax": 160,
  "dataCompleteness": {
    "complete": false,
    "missingFields": [
      "VIX"
    ],
    "optionalInputs": [
      "institutionalData"
    ],
    "requiredInputs": [
      "fundamentals",
      "marketContext.VIX",
      "marketContext.SPY",
      "marketContext.QQQ",
      "catalystData",
      "sentimentData",
      "ATR",
      "sector"
    ],
    "optionalInputWarnings": []
  },
  "technicalIndicators": {
    "adx": 85.71,
    "atr": {
      "atr": 3.2479,
      "rule": "ATR / current price; lower volatility scores higher",
      "score": 4,
      "atr_pct": 3.76
    },
    "cci": {
      "rule": "Cursor_18.24 CCI bands",
      "level": "適中偏強",
      "score": 8,
      "value": 58.78
    },
    "cmf": {
      "rule": "Cursor_18.24 CMF bands",
      "level": "輕微流入",
      "score": 6,
      "value": 0.1359
    },
    "kdj": {
      "d": 52.22,
      "j": 46.06,
      "k": 50.16,
      "rule": "Cursor_18.24 K/D cross",
      "score": 0,
      "signal": "死叉"
    },
    "mfi": {
      "rule": "Cursor_18.24 MFI bands",
      "level": "平衡",
      "score": 6,
      "value": 57.72
    },
    "obv": {
      "rule": "Cursor_18.24 recent_slope vs previous_slope",
      "score": 2,
      "trend": "資金流出",
      "value": -8781519,
      "recentSlope": -113551.9,
      "previousSlope": 41750
    },
    "rsi": 65.58,
    "sar": {
      "rule": "Cursor_18.24 Parabolic SAR",
      "score": 4,
      "trend": "下降",
      "value": 87.4219,
      "position": "SAR喺價上",
      "distancePct": 1.11,
      "previousTrend": "下降"
    },
    "ma50": 80.078,
    "macd": {
      "macd": 1.845239417514037,
      "trend": "中性偏多",
      "signal": 1.9444062794534713,
      "histogram": -0.09916686193943436
    },
    "vwap": {
      "rule": "Cursor_18.24 VWAP 20D consecutive close",
      "score": 8,
      "value": 84.3417,
      "position": "連續3日>VWAP",
      "consecutiveAbove": 4
    },
    "volume": {
      "rule": "Cursor_18.24 volume ratio",
      "level": "空升",
      "ratio": 0.61,
      "score": 2,
      "avgVolume": 1203449,
      "currentVolume": 733181
    },
    "derived": {
      "ma20": 83.499,
      "ma50": 80.078,
      "prevClose": 85.29,
      "avgVolume10": 1290578,
      "avgVolume20": 1203449,
      "changePercent": 1.37,
      "avgVolumeForScore": 1203449
    },
    "ma_cross": {
      "ma20": 83.499,
      "ma50": 80.078,
      "rule": "Cursor_18.24 MA20/MA50 cross",
      "cross": "多頭",
      "score": 4,
      "prevMa20": 83.261,
      "prevMa50": 79.8774,
      "spreadPct": 4.27,
      "isVolumeBreakout": false
    },
    "bollinger": {
      "lower": 76.025,
      "upper": 90.973,
      "position": "上半部"
    },
    "rsi_short": 45.06,
    "macd_short": {
      "macd": 0,
      "trend": "中性",
      "signal": 0,
      "histogram": 0
    },
    "volume_ratio": {
      "ratio": 0.61
    }
  }
}

{
  "close": 86.46,
  "volume": 733181,
  "changePercent": 1.37
}